BridgeMD
New treatment option for Excessive Hairiness
Official title Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
ClinicalTrials.gov ID: NCT06655129
What this study is testing
- What it's testing
- The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Adult men or women
- Excessive Hairiness:
- Patient with unwanted hair on the body (legs, arms, bikini line, or axilla)
- Patient over 18 years.
- Patients with Fitzpatrick skin types from I to V.
You likely can't join if
- Patients with history of malignant lesions or pre-malignant lesions, scarring, or infection in the area to be treated History of keloidal or...
- Patients with a known photosensitivity
- Pregnancy women
- Patient with diabetes mellitus suntan in the area to be treated
- Use of photo-sensitizing products for 7 days before treatment (selftanning lotions, activators, self-tanning shower gel, etc.)
- Exposure to the sun or UV rays at least 4 weeks before the treatment and 1 week afterwards
See the full eligibility criteria
- Adult men or women
- Excessive Hairiness:
- Patient with unwanted hair on the body (legs, arms, bikini line, or axilla)
- Patient over 18 years.
- Patients with Fitzpatrick skin types from I to V.
- Women were required to be post-menopausal, surgically sterilized, or under a medically acceptable form of birth control (i.e., oral contraceptives, IUD, contraceptive implant, or barrier methods with spermicide or...
- Patients over 18 years.
- Patients with Fitzpatrick skin types from I to IV.
- Patients with varicosities and Rosacea on the face or upper and lower limbs. Pigmented lesions:
- Patients over 18 years.
- Patients with solar lentigines on their cheeks, back, hands, arm and leg (\> 3 mm).
- Patient with Fitzpatrick skin type from I to IV. Acne:
- Patients over 18 years
- Patients with Fitzpatrick skin types from I to IV.
- Patients with facial acne vulgaris on face.
- Willing to sun protect treated area for the duration of enrollment in the study and 4 weeks after treatment.
- Patients with history of malignant lesions or pre-malignant lesions, scarring, or infection in the area to be treated History of keloidal or hypertrophic scarring
- Patients with a known photosensitivity
- Pregnancy women
- Patient with diabetes mellitus suntan in the area to be treated
- Use of photo-sensitizing products for 7 days before treatment (selftanning lotions, activators, self-tanning shower gel, etc.)
- Exposure to the sun or UV rays at least 4 weeks before the treatment and 1 week afterwards
- Zones with uncovered tattoos, suspect spots or skin diseases (including spots, inflammation, beauty spots, tumors or melanomas, psoriasis, herpes...)
- Use of medication that induces anticoagulative medication or thromboembolic condition
- Patients with pacemaker or internal defibrillator
- Patients that used of NSAIDS two weeks prior to or 2 weeks following the treatment
- Epileptic patients
- Additional criteria for excessive hair: Patients that use waxing or other methods of photo epilation within 1 month prior to treatment.
- Additional criteria for acne: Patients currently under oral antibiotic or oral therapy for acne.
The study team makes the final eligibility decision.
Where it's taking place
- Auxerre, France
- Brest, France
- Nice, France
- Périgueux, France
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Auxerre, France; Brest, France; Nice, France; Périgueux, France; Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.